Joint Filing AgreementJoint Filing Agreement • November 10th, 2015 • Steel Partners, Ltd. • Miscellaneous primary metal products
Contract Type FiledNovember 10th, 2015 Company IndustryIn accordance with Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13D (including amendments thereto) with respect to the Common Units, no par value, including Class B Common Units and Class C Common Units, of Steel Partners Holdings L.P. This Joint Filing Agreement shall be filed as an Exhibit to such Statement.
JOINT FILING AGREEMENTJoint Filing Agreement • November 26th, 2024 • Steel Partners, Ltd. • Services-management consulting services
Contract Type FiledNovember 26th, 2024 Company IndustryIn accordance with Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13D (including amendments thereto) with respect to the Common Stock, par value $0.01, of Wilhelmina International, Inc. This Joint Filing Agreement shall be filed as an Exhibit to such Statement.
STOCK PURCHASE AGREEMENTStock Purchase Agreement • November 1st, 2010 • Steel Partners, Ltd. • In vitro & in vivo diagnostic substances • New York
Contract Type FiledNovember 1st, 2010 Company Industry JurisdictionSTOCK PURCHASE AGREEMENT (the “Agreement”), dated as of October 21, 2010, by and among Ore Pharmaceutical Holdings Inc., a Delaware corporation, with headquarters located at One Main Street, Suite 300, Cambridge, Massachusetts 02142 (the “Company”), and Steel Partners, Ltd., a Delaware corporation (“Buyer”).
JOINT FILING AGREEMENTJoint Filing Agreement • November 1st, 2010 • Steel Partners, Ltd. • In vitro & in vivo diagnostic substances
Contract Type FiledNovember 1st, 2010 Company IndustryIn accordance with Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13D (including additional amendments thereto) with respect to the shares of Common Stock, $.01 par value, of Ore Pharmaceutical Holdings Inc.. This Joint Filing Agreement shall be filed as an Exhibit to such Statement.
Joint Filing AgreementJoint Filing Agreement • February 15th, 2018 • Steel Partners, Ltd. • Miscellaneous primary metal products
Contract Type FiledFebruary 15th, 2018 Company IndustryIn accordance with Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13D (including amendments thereto) with respect to the Common Units, no par value, including Class C Common Units, of Steel Partners Holdings L.P. This Joint Filing Agreement shall be filed as an Exhibit to such Statement.
Joint Filing AgreementJoint Filing Agreement • April 16th, 2012 • Steel Partners, Ltd. • Miscellaneous primary metal products
Contract Type FiledApril 16th, 2012 Company IndustryIn accordance with Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13D (including amendments thereto) with respect to the Common Units, no par value, including Class B Common Units, of Steel Partners Holdings L.P. This Joint Filing Agreement shall be filed as an Exhibit to such Statement.
UNIT PURCHASE PLANUnit Purchase Plan • March 30th, 2020 • Steel Partners, Ltd. • Miscellaneous primary metal products • New York
Contract Type FiledMarch 30th, 2020 Company Industry JurisdictionThis Unit Purchase Plan (the “Purchase Plan”) is entered into on March 25, 2020, by and between Morgan Stanley Smith Barney LLC, (“MSSB”) and Steel Partners Ltd. (“the Purchaser”) for the purchase of common units (the “Units”) issued by Steel Partners Holdings LP (SPLP) (the “Company”) to comply with the provisions of Rule 10b5-1 (“Rule 10b5-1”) and Rule 10b-18 (“Rule 10b-18”) under the Securities Exchange Act of 1934 on a “not held” basis.